Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.4M Buy
+1,386,098
New +$6.84M 0.29% 88
2025
Q2
Sell
-729,228
Closed -$5.66M 195
2025
Q1
$5.66M Sell
729,228
-1,443,106
-66% -$12.3M 0.29% 105
2024
Q4
$17.9M Sell
2,172,334
-251,188
-10% -$2.02M 0.85% 32
2024
Q3
$18M Sell
2,423,522
-489,798
-17% -$3.95M 0.99% 35
2024
Q2
$25.1M Buy
2,913,320
+165,867
+6% +$1.57M 1.22% 23
2024
Q1
$30.2M Buy
2,747,453
+512,618
+23% +$6.36M 1.6% 16
2023
Q4
$32.9M Buy
2,234,835
+116,432
+5% +$1.45M 1.5% 17
2023
Q3
$20.1M Buy
2,118,403
+81,361
+4% +$851K 0.85% 36
2023
Q2
$21.9M Buy
2,037,042
+1,637,668
+410% +$15.6M 1.11% 33
2023
Q1
$3.53M Buy
+399,374
New +$4.21M 0.2% 108

Other funds holding UDMY

Invenomic Capital Management's UDMY Position: Q1 2026 in Review

Invenomic Capital Management opened a new position in Udemy (UDMY) in Q1 2026: 1,386,098 shares worth $6.4M. The stake represents 0.29% of the portfolio and ranks #88 among its holdings. This is a return to the name: Invenomic Capital Management previously reported a position in UDMY as recently as Q1 2025.

Invenomic Capital Management first reported a position in UDMY in Q1 2023 and has held it in 10 quarters since. The position peaked at $32.9M in Q4 2023. 194 funds tracked by Wall St. Rank hold UDMY as of Q1 2026.

  • Invenomic Capital Management held 1,386,098 shares of Udemy worth $6.4M as of Q1 2026.
  • Udemy was a new Invenomic Capital Management position in Q1 2026.
  • Udemy made up 0.29% of Invenomic Capital Management's portfolio in Q1 2026, its #88 holding.
  • Invenomic Capital Management first reported a position in Udemy in Q1 2023 and has held it in 10 quarters since.
  • Invenomic Capital Management's Udemy position peaked at $32.9M in Q4 2023.
  • 194 funds tracked by Wall St. Rank held Udemy as of Q1 2026.

Based on Invenomic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.